Your browser doesn't support javascript.
loading
The severe cytokine release syndrome in phase I trials of CD19-CAR-T cell therapy: a systematic review.
Jin, Zhen; Xiang, Rufang; Qing, Kai; Li, Xiaoyang; Zhang, Yunxiang; Wang, Lining; Zhu, Hongming; Mao, Yuanfei; Xu, Zizhen; Li, Junmin.
Afiliación
  • Jin Z; Department of Hematology, Ruijin Hospital affiliated to School of Medicine, Shanghai Jiao Tong University, Ruijin Er Road 197, Shanghai, China.
  • Xiang R; Shanghai Institute of Hematology, Ruijin Hospital affiliated to School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Qing K; Department of Hematology, Ruijin Hospital affiliated to School of Medicine, Shanghai Jiao Tong University, Ruijin Er Road 197, Shanghai, China.
  • Li X; Shanghai Institute of Hematology, Ruijin Hospital affiliated to School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Zhang Y; Department of Hematology, Ruijin Hospital affiliated to School of Medicine, Shanghai Jiao Tong University, Ruijin Er Road 197, Shanghai, China.
  • Wang L; Shanghai Institute of Hematology, Ruijin Hospital affiliated to School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Zhu H; Department of Hematology, Ruijin Hospital affiliated to School of Medicine, Shanghai Jiao Tong University, Ruijin Er Road 197, Shanghai, China.
  • Mao Y; Shanghai Institute of Hematology, Ruijin Hospital affiliated to School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Xu Z; Department of Hematology, Ruijin Hospital affiliated to School of Medicine, Shanghai Jiao Tong University, Ruijin Er Road 197, Shanghai, China.
  • Li J; Shanghai Institute of Hematology, Ruijin Hospital affiliated to School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Ann Hematol ; 97(8): 1327-1335, 2018 Aug.
Article en En | MEDLINE | ID: mdl-29766234
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Inmunoterapia Adoptiva / Linfoma de Células B / Antígenos CD19 / Leucemia-Linfoma Linfoblástico de Células Precursoras / Receptores Quiméricos de Antígenos Tipo de estudio: Etiology_studies / Risk_factors_studies / Systematic_reviews Límite: Female / Humans / Male Idioma: En Revista: Ann Hematol Asunto de la revista: HEMATOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Inmunoterapia Adoptiva / Linfoma de Células B / Antígenos CD19 / Leucemia-Linfoma Linfoblástico de Células Precursoras / Receptores Quiméricos de Antígenos Tipo de estudio: Etiology_studies / Risk_factors_studies / Systematic_reviews Límite: Female / Humans / Male Idioma: En Revista: Ann Hematol Asunto de la revista: HEMATOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: China